Literature DB >> 12820735

Infection in ventricular assist devices: prevention and treatment.

William L Holman1, Barry K Rayburn, David C McGiffin, Brian A Foley, Raymond L Benza, Robert C Bourge, Laura J Pinderski, James K Kirklin.   

Abstract

Infection is one of the most important challenges to the use of implanted mechanical circulatory support systems (MCSS), particularly as we enter the era of permanent device use in patients who are not candidates for cardiac transplantation. This paper describes the pathogenesis of MCSS infection, with particular attention to the role of biofilm-forming bacteria. Suggestions are presented for the prevention and treatment of infections in implanted MCSS.

Entities:  

Mesh：

Year:  2003        PMID： 12820735     DOI： 10.1016/s0003-4975(03)00479-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN： 0003-4975            Impact factor:   4.330


  17 in total

1.  Left Ventricular Assist Devices as Destination Therapy for End-stage Heart Failure.

Authors:  Lynne Warner Stevenson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-12

2.  Cardiac assist device infections.

Authors:  Shmuel Shoham; Leslie W Miller
Journal:  Curr Infect Dis Rep       Date:  2009-07       Impact factor: 3.725

Review 3.  Mechanical circulatory support.

Authors:  Deborah J Kozik; Mark D Plunkett
Journal:  Organogenesis       Date:  2011-01-01       Impact factor: 2.500

Review 4.  Technique for minimizing and treating driveline infections.

Authors:  Leora T Yarboro; James D Bergin; Jamie L W Kennedy; Carole C Ballew; Emily M Benton; Gorav Ailawadi; John A Kern
Journal:  Ann Cardiothorac Surg       Date:  2014-11

Review 5.  Analysis of bacterial biofilms using NMR-based metabolomics.

Authors:  Bo Zhang; Robert Powers
Journal:  Future Med Chem       Date:  2012-06       Impact factor: 3.808

6.  Infection management in a patient with a left ventricular assist device: a case report of long-term cefazolin sodium hydrate administration.

Authors:  Eiki Tayama; Koichi Arinaga; Takahiro Shojima; Kazuyoshi Takagi; Yoshinori Yokokura; Kazuhiro Yoshikawa; Hidetsugu Hori; Shuji Fukunaga; Hidetoshi Akashi; Shigeaki Aoyagi
Journal:  J Artif Organs       Date:  2006       Impact factor: 1.731

7.  Minimally invasive approach to thoracic effusions in patients with ventricular assist devices.

Authors:  Sebastien Gilbert; Arman Kilic; Karl Yaeger; Yoshiya Toyoda; Christian Bermudez; Michael P Siegenthaler; Robert L Kormos
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-11-18

Review 8.  [Infection control measures and surveillance of patients with ventricular assist devices].

Authors:  F Mattner; I F Chaberny; L Mattner; P Gastmeier; R Tessmann; M Strüber
Journal:  Anaesthesist       Date:  2007-05       Impact factor: 1.041

9.  Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation.

Authors:  Elizabeth A Genovese; Mary Amanda Dew; Jeffrey J Teuteberg; Marc A Simon; Joy Kay; Michael P Siegenthaler; Jay K Bhama; Christian A Bermudez; Kathleen L Lockard; Steve Winowich; Robert L Kormos
Journal:  Ann Thorac Surg       Date:  2009-10       Impact factor: 4.330

10.  SdrF, a Staphylococcus epidermidis surface protein, contributes to the initiation of ventricular assist device driveline-related infections.

Authors:  Carlos Arrecubieta; Faustino A Toba; Manuel von Bayern; Hirokazu Akashi; Mario C Deng; Yoshifumi Naka; Franklin D Lowy
Journal:  PLoS Pathog       Date:  2009-05-01       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.